Medication adherence may be a proxy for healthy behaviors and other factors that affect outcomes. Prior studies of the association between placebo adherence and health outcomes have been limited primarily to men enrolled in clinical trials and cardiovascular disease outcomes. We examined associations between adherence to placebo and the risk of fracture, coronary heart disease, cancer, and all-cause mortality in the two Women’s Health Initiative (WHI) hormone therapy randomized trials
OBJECTIVE: A previous study suggests an association between poor medication adherence and excess mor...
Objectives: Side effects from Hormone Therapy (HT) impact medication adherence in breast cancer surv...
Dual-outcome intention-to-treat hazard rate analyses have potential to complement single-outcome ana...
BackgroundMedication adherence may be a proxy for healthy behaviors and other factors that affect ou...
BackgroundAnalyses from double-blind randomized trials have reported lower mortality among participa...
A provocative finding from several double-blind clinical trials has been the association between gre...
Background: The survival difference between adherers and non-adherers to placebo in the Coronary Dru...
Objective: This study examined the relationship between adherence, mortality, and psychosocial facto...
The authors analyzed data from the Women\u27s Health Initiative (WHI) Calcium and Vitamin D Suppleme...
PURPOSE To investigate adherence to endocrine treatment and its relationship with disease-free su...
Despite the proven clinical benefits of use of adjuvant hormone therapy with tamoxifen or aromatase ...
Purpose: To investigate adherence to endocrine treatment and its relationship with disease-free surv...
Increasing duration of tamoxifen therapy improves survival in women with breast cancer but the impac...
To evaluate adherence to oral hormone therapy (HT) and which factors impact in incomplete adherence ...
Although many patients with heart failure have incomplete adherence to prescribed medications, predi...
OBJECTIVE: A previous study suggests an association between poor medication adherence and excess mor...
Objectives: Side effects from Hormone Therapy (HT) impact medication adherence in breast cancer surv...
Dual-outcome intention-to-treat hazard rate analyses have potential to complement single-outcome ana...
BackgroundMedication adherence may be a proxy for healthy behaviors and other factors that affect ou...
BackgroundAnalyses from double-blind randomized trials have reported lower mortality among participa...
A provocative finding from several double-blind clinical trials has been the association between gre...
Background: The survival difference between adherers and non-adherers to placebo in the Coronary Dru...
Objective: This study examined the relationship between adherence, mortality, and psychosocial facto...
The authors analyzed data from the Women\u27s Health Initiative (WHI) Calcium and Vitamin D Suppleme...
PURPOSE To investigate adherence to endocrine treatment and its relationship with disease-free su...
Despite the proven clinical benefits of use of adjuvant hormone therapy with tamoxifen or aromatase ...
Purpose: To investigate adherence to endocrine treatment and its relationship with disease-free surv...
Increasing duration of tamoxifen therapy improves survival in women with breast cancer but the impac...
To evaluate adherence to oral hormone therapy (HT) and which factors impact in incomplete adherence ...
Although many patients with heart failure have incomplete adherence to prescribed medications, predi...
OBJECTIVE: A previous study suggests an association between poor medication adherence and excess mor...
Objectives: Side effects from Hormone Therapy (HT) impact medication adherence in breast cancer surv...
Dual-outcome intention-to-treat hazard rate analyses have potential to complement single-outcome ana...